HP is the global leader in inkjet printing for liquid microelectromechanical systems (MEMS) devices. Over the past three decades, HP has invested billions of dollars in research and development and capital equipment, creating the world’s largest digital printing company. This has laid the foundation for expanding this technology into new areas. HP’s Professional Printing Systems (SPS) team, in collaboration with the Microfluidics Technology and Operations (MTO) team, brought to market HP’s first life sciences solution in this area: the HP D300e inkjet-powered BioPrinter that automates lab dispensing by “printing” pharmaceutical samples without the use of ink. The bioprinter is used by labs and pharmaceutical companies around the world, including the Centers for Disease Control and Prevention’s (CDC) Antimicrobial Resistance (AR) Laboratory Network, where it performs antimicrobial susceptibility testing for health departments and hospitals across the country. *NEWS* On July 13, 2020, HP announced an update to its COVID-19 response by donating bioprinters to research institutions in the US and Europe, the Middle East and Africa to accelerate research into drugs and vaccines to combat the pandemic.
Learn more about the HP BioPrinter | HP’s response to COVID-19 | About HP channel partner Tecan | Antibiotic resistance lab network
The U.S. Centers for Disease Control and Prevention (CDC) has purchased an HP BioPrinter for a pilot project designed to speed up testing of new antibiotics to combat antimicrobial-resistant bacteria.
Watch Dr. David Donner, Director of the Surgical Oncology Research Laboratory, discuss the benefits of innovative microfluidic technologies in cancer research.
The HP D300e bioprinter made a splashy debut in the 12th episode of ABC’s The Good Doctor season 2. More than 12 million viewers tuned in to see the show’s lead, Dr. Shaun Murphy (played by actor Freddie Highmore), marvel at the technology and ask, “Is this a D300e bioprinter that’s resistant to pathogens? Are you studying antibiotic resistance in emerging microorganisms?” The program concluded with a “demonstration” of the D300e.
© 2020 HP Development Company LP. The information contained herein is subject to change without notice. The only warranties for HP Inc. products and services are set forth in the express warranty statements accompanying such products and services. Nothing herein should be construed as constituting an additional warranty. HP Inc. shall not be liable for technical or editorial errors or omissions contained herein.
HP Inc. (NYSE: HPQ) is a global technology leader and solutions developer that helps people bring their ideas to life and solve their most important problems. With operations in more than 170 countries, HP offers a broad range of innovative, environmentally friendly devices, services and subscriptions across computing, printing, 3D printing, hybrid workspaces, gaming and more. Learn more at HP.com. Contact: MediaRelations@hp.com
©2025 HP Development Company, LP The information contained herein is subject to change without notice.
Post time: Aug-23-2025